The KKR-backed air and ground emergency medical services company plans to sell nearly 32 million shares at $22 to $25 each in a filing to the US Securities and Exchange Commission.
GMR, known as Global Medical Response, is pursuing the listing as healthcare companies increasingly turn to public markets to raise capital.
The deal would add another healthcare name to the US IPO pipeline, testing investor appetite for emergency medical services providers.
As GMR targets an $800M IPO, can it profit while the rural EMS system it relies on is teetering on collapse?
Will GMR's IPO cash unlock AI's life-saving potential, or will the broken economics of emergency care block innovation?